Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

Human skin cells contain Protease Nexin-1, and male hormones can decrease its levels, potentially affecting hair growth.

PRP and HF-MSCs treatment improves hair growth, thickness, and density in androgenetic alopecia.

Minoxidil can reduce functions related to androgen receptors.

Testosterone affects hair follicles differently across body sites, with beard hair follicles showing more activity of a specific enzyme and presence of androgen receptors compared to scalp hair.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Stauntonia hexaphylla extract can help treat hair loss by blocking certain hormones.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

PRP is effective for treating hair loss, especially with other treatments.

Wnt/β-catenin and TGF-β pathways affect hair loss, and activating Wnt/β-catenin could be a potential treatment.

Ginsenoside Re from ginseng may help hair grow by blocking a specific growth-inhibiting pathway.

Eccrine sweat gland's clear cells likely cause excessive sweating in hyperhidrosis.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Hormones, especially androgens, play a big role in acne, but most acne sufferers don't have a hormone disorder. Hormonal treatments, including birth control pills, can be very effective for women whose acne doesn't improve with regular treatments.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

DHT, a testosterone byproduct, causes male pattern baldness.

Mice with human gene experienced hair loss when treated with DHT.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Hirsutism causes significant psychological distress in women.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.